Date published: 2026-5-7

1-800-457-3801

SCBT Portrait Logo
Seach Input

CA V Inhibitors

CA V inhibitors, also known as calcium channel V inhibitors, belong to a specific chemical class of compounds that interact with calcium channels in various biological systems. These inhibitors are designed to selectively target and modulate the activity of calcium channels belonging to the CA V subtype. Calcium channels play a crucial role in regulating the influx of calcium ions into cells, which is involved in numerous physiological processes such as muscle contraction, neurotransmitter release, and intracellular signaling. CA V inhibitors specifically target the CA V subtype of calcium channels, which are predominantly found in certain tissues and organs. The mechanism of action of CA V inhibitors involves binding to specific sites on the calcium channels, leading to a reduction or prevention of calcium ion entry into the cells. By modulating calcium influx, these inhibitors have the potential to influence various cellular functions and signaling pathways. Due to their selective targeting of CA V calcium channels, these inhibitors may offer a specific and precise means of modulating calcium signaling in specific tissues or organs. The chemical structures of CA V inhibitors can vary depending on the specific compound and its design. However, they generally possess certain structural features that facilitate their binding to the CA V calcium channels. These compounds are typically small organic molecules that exhibit specific functional groups and spatial arrangements, enabling them to interact with the calcium channel proteins in a selective and potent manner. In summary, CA V inhibitors constitute a chemical class of compounds that selectively interact with and modulate the activity of calcium channels belonging to the CA V subtype. By targeting these channels, these inhibitors have the potential to influence calcium ion entry into cells and modulate various physiological processes. The chemical structures of CA V inhibitors are designed to enable their specific binding to the CA V calcium channels, thus offering a promising avenue for further research and exploration in the field of calcium channel modulation.
Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Dorzolamide Hydrochloride

130693-82-2sc-207596
10 mg
$186.00
(1)

Dorzolamide Hydrochloride exhibits unique properties as a sulfonamide derivative, featuring a sulfonamide group that enhances its solubility in aqueous environments. Its molecular interactions are characterized by hydrogen bonding and dipole-dipole interactions, which facilitate its binding to target sites. The compound's structural conformation allows for specific steric interactions, influencing its reactivity and stability in various chemical environments, making it a subject of interest in studies of molecular dynamics and solvation effects.

Brinzolamide

138890-62-7sc-481649
10 mg
$269.00
(0)

Brinzolamide is another CA V inhibitor used in the research of open-angle glaucoma and ocular hypertension. It works similarly to dorzolamide by reducing the production of aqueous humor.

Sulthiame

61-56-3sc-474559
sc-474559A
25 mg
250 mg
$357.00
$2497.00
(0)

Sultiame is an antiepileptic that exhibits both CA V inhibitory and GABAergic activity. It is used in the research of epilepsy, particularly absence seizures.